Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05566262 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bodewell Products for the Treatment of Atopic Dermatitis

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Feb 2026 to Feb 2027 Trial status: Recruiting to Active, Not Recruiting · Completion date: Feb 2027 to Feb 2028 · Site details revisedv9 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Feb 2027 to Feb 2028
    • Site details revised
  2. Primary completion date: Sep 2025 to Feb 2026 Completion date: Sep 2026 to Feb 2027v8 Show 1 more changeShow less
    • Completion date: Sep 2026 to Feb 2027
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jan 2024 to Nov 1, 2023 · Site details revisedv7 Show 2 more changesShow less
    • Start date changed from estimate of Jan 2024 to Nov 1, 2023
    • Site details revised
  4. Primary completion date: Sep 2024 to Sep 2025 Start date: Aug 2023 to Jan 2024 · Completion date: Sep 2025 to Sep 2026v6 Show 2 more changesShow less
    • Start date: Aug 2023 to Jan 2024
    • Completion date: Sep 2025 to Sep 2026
  5. Start date: May 2023 to Aug 2023 Primary completion date: Jun 2024 to Sep 2024 · Completion date: Jun 2025 to Sep 2025v5 Show 2 more changesShow less
    • Primary completion date: Jun 2024 to Sep 2024
    • Completion date: Jun 2025 to Sep 2025
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Feb 2023 to May 2023 Primary completion date: Mar 2024 to Jun 2024 · Completion date: Mar 2025 to Jun 2025v4 Show 2 more changesShow less
    • Primary completion date: Mar 2024 to Jun 2024
    • Completion date: Mar 2025 to Jun 2025
  2. Start date: Oct 2022 to Feb 2023 Primary completion date: Dec 2023 to Mar 2024 · Completion date: Dec 2024 to Mar 2025v3 Show 2 more changesShow less
    • Primary completion date: Dec 2023 to Mar 2024
    • Completion date: Dec 2024 to Mar 2025
  3. Primary endpoint revised Secondary endpoints: details revised at 1 of 1 entryv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 1 entry

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to examine the safety and efficacy of topical application of the Bodewell eczema products
Trial Details
NCT Number NCT05566262
Lead Sponsor University of Alabama at Birmingham
Collaborators: Procter and Gamble
Conditions Atopic Dermatitis
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov